Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- RefSeek
- Hamdard University
- EBSCO A-Z
- SWB online catalog
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Advances in Pharmacoepidemiology and Drug Safety have been cited by esteemed scholars and scientists all around the world. Advances in Pharmacoepidemiology and Drug Safety has got h-index 14, which means every article in Advances in Pharmacoepidemiology and Drug Safety has got 14 average citations.
Following are the list of articles that have cited the articles published in Advances in Pharmacoepidemiology and Drug Safety.
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
Year wise published articles |
30 | 32 | 23 | 3 | 4 |
Year wise citations received |
71 | 95 | 59 | 87 | 69 |
| Journal total citations count | 654 |
| Journal Impact Factor | 2.86 |
| Journal 5 years Impact Factor | 4.33 |
| Journal CiteScore | 5.34 |
| Journal h-index | 14 |
Important citations
Monico LB, Mitchell SG, Gryczynski J, Schwartz RP, O’Grady KE, Olsen YK, Jaffe JH. Prior experience with non-prescribed buprenorphine: Role in treatment entry and retention. Journal of substance abuse treatment. 2015 Oct 1;57:57-62.
Soyka M. New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone. Substance abuse and rehabilitation. 2015;6:1.
Dematteis M, Auriacombe M, D’Agnone O, Somaini L, Szerman N, Littlewood R, Alam F, Alho H, Benyamina A, Bobes J, Daulouede JP. Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus. Expert opinion on pharmacotherapy. 2017 Dec 12;18(18):1987-99.
Kaur G, Bhagat S, Sahni D, Sharma V, Mohan A. A comparative study of budesonide versus saline irrigations in postoperative care of patients with nasal polyposis. B-ENT. 2020 Jan 1;16(2):91-6.
Chatterjee A. Research & Reviews: Journal of Hospital and Clinical Pharmacy.
Brown HJ, Batra PS, Eggerstedt M, Ganti A, Papagiannopoulos P, Tajudeen BA. The possibility of short?term hypothalamic?pituitary?adrenal axis suppression with high?volume, high?dose nasal mometasone irrigation in postsurgical patients with chronic rhinosinusitis. InInternational Forum of Allergy & Rhinology 2021 Sep 26.
Nguyen TP, Patel ZM. Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss. InInternational forum of allergy & rhinology 2018 Sep (Vol. 8, No. 9, pp. 977-981).
Alomi YA, Alaskari DA, Almelfi MM, Badawi DA, Alshihri AM. Healthcare Provider’s Perception and Attitude of Medications in Kingdom of Saudi Arabia. Age. 2018;18(5):2-66.
Alomi YA, Almasoudi AH, Al-Hathlool SA, Almulhim MI, Aboshalaf Y, Al-Ethan M. Patient's Perception of Pharmaceutical Care Services; Challenges and Improving in Saudi Arabia. International Journal of Pharmacology and Clinical Sciences. 2019;8(3).
Alomi YA, Alghamdi SJ, Alattyh RA. National Survey of Drug Information Centers Practice in Saudi Arabia: Medication-Use Evaluation System at Ministry of Health Hospitals. J Pharmacovigil. 2017;5(245):2.
Alomi YA, Alghamdi SJ, Alattyh RA. National Survey of Drug Information Centers Practice in Saudi Arabia: Medication-Use Evaluation System at Ministry of Health Hospitals. J Pharmacovigil. 2017;5(245):2.
Smith KA, French G, Mechor B, Rudmik L. Safety of long?term high?volume sinonasal budesonide irrigations for chronic rhinosinusitis. InInternational forum of allergy & rhinology 2016 Mar (Vol. 6, No. 3, pp. 228-232).
Alomi YA, Alshammari AM. Analysis of Practice of Drug Information Resources by Dentists in Saudi Arabia. PTB Reports. 2021;7(1).
Alomi YA, Al Qahtani N, Alsulami N, Al Qahtani MM, Almansor FA. Analysis of Drug Information Inquires at a Mental Hospital in Saudi Arabia. Pharmacoeconomics. 2018;1:0-9.
Alomi YA, Alghamdi SJ, Alattyh RA. National Survey of Drug Information Centers practice: Leadership and Practice management at Ministry of Health Hospital in Saudi Arabia.
Alomi YA, Alsulami N, Al Qahtani N, Al Qahtani MM, Almansor FA. Cost Avoidance of Drug Information Services at the Mental Hospital in Saudi Arabia. Journal of Pharmacy Practice and Community Medicine. 2018;4(2).
Alomi YA, Alabdullatif AA, Awadh A, Alharbi AF. Basic pharmacy research knowledge in the Kingdom of Saudi Arabia.
Alomi YA, Al-Jarallah SM, Bahadig FA. Cost-efficiency of Clinical Pharmacy Services at Ministry of Health Hospital, Riyadh City, Saudi Arabia. Pharmacology, Toxicology and Biomedical Reports. 2019;5(3s).
Alomi YA, Alghamdi SJ, Alattyh RA. National workload analysis of a network of drug information centres at the ministry of health hospitals in Saudi Arabia. International Journal of Pharmacy and Health Sciences. 2018;1(1).
Bennett CL, Hoque S, Olivieri N, Taylor MA, Aboulafia D, Lubaczewski C, Bennett AC, Vemula J, Schooley B, Witherspoon BJ, Godwin AC. Consequences to patients, clinicians, and manufacturers when very serious adverse drug reactions are identified (1997–2019): A qualitative analysis from the Southern Network on Adverse Reactions (SONAR). EClinicalMedicine. 2021 Jan 1;31:100693.